Enzo Biochem (ENZ) News Today $0.98 -0.01 (-0.70%) (As of 10:30 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Enzo Biochem (NYSE:ENZ) Now Covered by StockNews.comStockNews.com began coverage on Enzo Biochem in a research note on Friday. They set a "hold" rating for the company.November 15, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Stock, Option ChainNovember 11, 2024 | benzinga.comEnzo Biochem, Inc.: Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendNovember 4, 2024 | finanznachrichten.deEnzo Biochem Reports Revenue Growth Despite LossesOctober 31, 2024 | markets.businessinsider.comEnzo Biochem Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.51 loss in FY 2023)October 31, 2024 | finance.yahoo.comWe're Keeping An Eye On Enzo Biochem's (NYSE:ENZ) Cash Burn RateOctober 31, 2024 | finance.yahoo.comEnzo Biochem (NYSE:ENZ) Stock Price Passes Above 200 Day Moving Average - Should You Sell?Enzo Biochem (NYSE:ENZ) Shares Pass Above Two Hundred Day Moving Average - Should You Sell?October 30, 2024 | marketbeat.comEnzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash DividendOctober 29, 2024 | globenewswire.comEnzo Biochem (NYSE:ENZ) Research Coverage Started at StockNews.comStockNews.com started coverage on Enzo Biochem in a research report on Tuesday. They issued a "hold" rating on the stock.October 22, 2024 | marketbeat.comEnzo Biochem, Inc. (NYSE:ENZ) Sees Significant Increase in Short InterestEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totalling 518,000 shares, a growth of 8.2% from the September 15th total of 478,700 shares. Approximately 1.4% of the shares of the stock are short sold. Based on an average daily volume of 74,600 shares, the days-to-cover ratio is currently 6.9 days.October 17, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Now Covered by Analysts at StockNews.comStockNews.com initiated coverage on shares of Enzo Biochem in a report on Monday. They set a "hold" rating for the company.October 14, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comStockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)StockNews.com started coverage on shares of Enzo Biochem in a research note on Sunday. They set a "hold" rating on the stock.October 6, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Shares Pass Above 200-Day Moving Average of $1.13Enzo Biochem (NYSE:ENZ) Stock Passes Above Two Hundred Day Moving Average of $1.13September 28, 2024 | marketbeat.comRecombinant Proteins Market Size to Reach USD 5.0 Billion by 2032, at a CAGR of 7.6% - SNS InsiderSeptember 25, 2024 | finance.yahoo.comWorried About Financial Fraud After A Healthcare Data Breach? Here's What You Can DoSeptember 25, 2024 | forbes.comConnecticut Attorney General announces $1.7 million false claims settlement with Enzo Clinical LabsSeptember 21, 2024 | msn.comEnzo Biochem Inc (EZB.DU)September 20, 2024 | ca.finance.yahoo.comEnzo Biochem (NYSE:ENZ) Coverage Initiated by Analysts at StockNews.comStockNews.com assumed coverage on shares of Enzo Biochem in a report on Friday. They issued a "hold" rating for the company.September 20, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Share Price Crosses Above 200-Day Moving Average of $1.14Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above 200-Day Moving Average of $1.14September 20, 2024 | marketbeat.comShort Interest in Enzo Biochem, Inc. (NYSE:ENZ) Declines By 10.0%Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the recipient of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 531,800 shares, a decline of 10.0% from the July 15th total of 591,200 shares. Based on an average trading volume of 119,600 shares, the short-interest ratio is presently 4.4 days. Currently, 1.5% of the shares of the stock are sold short.August 18, 2024 | marketbeat.comUnicoin hints at potential data meddling after G-Suite compromiseAugust 16, 2024 | msn.comBiotech company settles for $4.5M after cybercriminals use decade-old password in massive data breach: NY AGAugust 14, 2024 | msn.comEnzo Biochem to pay $4.5m for leaked healthcare data due to lax securityAugust 14, 2024 | finance.yahoo.comEnzo Biochem ordered to cough up $4.5 million over lousy security that led to ransomware disasterAugust 14, 2024 | msn.comEnzo Biochem to pay $4.5 million over cyberattack, NY attorney general saysAugust 14, 2024 | msn.comEnzo Biochem to Pay $4.5 Million for Failing to Safeguard Patient DataAugust 14, 2024 | usnews.comParamount laying off another 15 percent of its US workforceAugust 14, 2024 | sg.news.yahoo.com10-year-old passwords helped hackers get company’s customer info, AG saysAugust 14, 2024 | nj.comEnzo Biochem penalized $4.5M over data breachAugust 14, 2024 | msn.comEnzo Biochem to pay $4.5 mln for failing to safeguard patient dataAugust 13, 2024 | reuters.comRare Stock Picks In July 2024 - From 29 Discerning AnalystsAugust 6, 2024 | seekingalpha.comENZ Enzo Biochem, Inc.July 25, 2024 | seekingalpha.comShort Interest in Enzo Biochem, Inc. (NYSE:ENZ) Expands By 8.0%Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 605,300 shares, an increase of 8.0% from the June 15th total of 560,500 shares. Approximately 1.7% of the shares of the stock are short sold. Based on an average daily volume of 132,100 shares, the short-interest ratio is presently 4.6 days.July 18, 2024 | marketbeat.comShort Interest in Enzo Biochem, Inc. (NYSE:ENZ) Declines By 6.9%Enzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a significant drop in short interest during the month of June. As of June 15th, there was short interest totalling 560,500 shares, a drop of 6.9% from the May 31st total of 602,300 shares. Currently, 1.6% of the shares of the stock are sold short. Based on an average daily volume of 114,700 shares, the days-to-cover ratio is presently 4.9 days.July 3, 2024 | marketbeat.comENZ Stock Earnings: Enzo Biochem Reported Results for Q3 2024June 14, 2024 | investorplace.comEnzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business UpdateJune 13, 2024 | globenewswire.comEnzo Biochem, Inc. (ENZ)May 19, 2024 | finance.yahoo.comIn Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarketsMarch 28, 2024 | finanznachrichten.deEnzo Biochem, Inc. (NYSE:ENZ) Sees Large Decrease in Short InterestEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 29th, there was short interest totalling 715,400 shares, a decrease of 9.8% from the February 14th total of 792,900 shares. Approximately 2.1% of the company's shares are sold short. Based on an average daily trading volume, of 113,500 shares, the short-interest ratio is presently 6.3 days.March 18, 2024 | marketbeat.comEnzo Biochem, Inc.: Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateMarch 14, 2024 | finanznachrichten.deEnzo Biochem (NYSE:ENZ) shareholders have endured a 69% loss from investing in the stock three years agoMarch 14, 2024 | finance.yahoo.comEnzo Biochem: Fiscal Q2 Earnings SnapshotMarch 13, 2024 | finance.yahoo.comEnzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateMarch 13, 2024 | globenewswire.comEnzo Biochem, Inc. (NYSE:ENZ) Short Interest UpdateEnzo Biochem, Inc. (NYSE:ENZ - Get Free Report) saw a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 792,900 shares, a growth of 5.1% from the January 31st total of 754,700 shares. Based on an average trading volume of 112,600 shares, the days-to-cover ratio is presently 7.0 days. Currently, 2.3% of the company's shares are short sold.March 6, 2024 | marketbeat.comEnzo Biochem (NYSE:ENZ) Stock Passes Above Two Hundred Day Moving Average of $1.38Enzo Biochem (NYSE:ENZ) Stock Price Crosses Above Two Hundred Day Moving Average of $1.38February 17, 2024 | marketbeat.comEnzo Biochem, Inc.February 16, 2024 | money.usnews.comJim Simons Trims Stake in Enzo Biochem IncFebruary 14, 2024 | finance.yahoo.comEnzo Biochem Shareholders Elect Directors, Reject Exec PayFebruary 2, 2024 | msn.comEnzo Biochem Appoints New CEO and CFOFebruary 2, 2024 | msn.com Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address This Bull Market Indicator called NVDA at $116 (Ad)Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here ENZ Media Mentions By Week ENZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENZ News Sentiment▼0.000.46▲Average Medical News Sentiment ENZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENZ Articles This Week▼11▲ENZ Articles Average Week Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sera Prognostics News Today Biodesix News Today EUDA Health News Today Quipt Home Medical News Today Exagen News Today P3 Health Partners News Today Burning Rock Biotech News Today Concord Medical Services News Today Marpai News Today OpGen News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ENZ) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzo Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ENZ Stock Alerts